Dr. Liang Juan obtained her Ph.D. in Biomedical Sciences from The Chinese University of Hong Kong. After graduating, she undertook postdoctoral research at Queen’s University Belfast and later served as an Associate Researcher at Nanjing University. In 2020, she joined Gempharmatech and she is Currently the director of Research and Development Center, having previously held positions such as Principal Investigator in the autoimmune disease research pipeline.
Dr. Liang has extensive experience in the development of transgenic and disease mice models. Her primary research focus lies in the development of preclinical animal models for induced and spontaneous autoimmune diseases, as well as the establishment of related efficacy testing systems. These efforts are crucial for advancing the development of new treatments and drugs for autoimmune diseases.
Early bird registration is open and closes May 2025. Register now
